Cited by 46

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Differential use of E2 ubiquitin conjugating enzymes for regulated degradation of the rate-limiting enzymes HMGCR and SQLE in cholesterol biosynthesis

Tan, Josephine M.E., Cook, Emma C.L., van den Berg, Marlene, Scheij, Saskia, Zelcer, Noam, Loregger, Anke·2019·Atherosclerosis

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.atherosclerosis.2018.12.008

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 27

  1. Maxfield, 2010, Cholesterol, the central lipid of mammalian cells, Curr. Opin. Cell Biol., 22, 422, 10.1016/j.ceb.2010.05.004 · DOI · Paper page
  2. Brown, 1997, 89, 1
  3. Sharpe, 2014, The UPS and downs of cholesterol homeostasis, Trends Biochem. Sci., 39, 527, 10.1016/j.tibs.2014.08.008 · DOI · Paper page
  4. Gill, 2011, Cholesterol-dependent degradation of squalene monooxygenase, a control point in cholesterol synthesis beyond HMG-CoA reductase, Cell Metabol., 13, 260, 10.1016/j.cmet.2011.01.015 · DOI · Paper page
  5. Stevenson, 2014, Squalene mono-oxygenase, a key enzyme in cholesterol synthesis, is stabilized by unsaturated fatty acids, Biochem. J., 461, 10.1042/BJ20131404 · DOI
  6. Song, 2005, Insig-mediated degradation of HMG CoA reductase stimulated by lanosterol, an intermediate in the synthesis of cholesterol, Cell Metabol., 1, 179, 10.1016/j.cmet.2005.01.001 · DOI
  7. Yang, 2006, Sterol intermediates from cholesterol biosynthetic pathway as liver X receptor ligands, J. Biol. Chem., 281, 27816, 10.1074/jbc.M603781200 · DOI
  8. DeBose-Boyd, 2008, Feedback regulation of cholesterol synthesis: sterol- accelerated ubiquitination and degradation of HMG CoA reductase, Cell Res., 18, 609, 10.1038/cr.2008.61 · DOI · Paper page
  9. Howe, 2015, The regulatory domain of squalene monooxygenase contains a re-entrant loop and senses cholesterol via a conformational change, J. Biol. Chem., 290, 27533, 10.1074/jbc.M115.675181 · DOI
  10. Stewart, 2016, E2 enzymes: more than just middle men, Cell Res., 26, 423, 10.1038/cr.2016.35 · DOI
  11. Loregger, 2017, Haploid mammalian genetic screen identifies UBXD8 as a key determinant of HMGCR degradation and cholesterol biosynthesis, Arterioscler. Thromb. Vasc. Biol., 37, 2064, 10.1161/ATVBAHA.117.310002 · DOI
  12. Jiang, 2014, Ubiquitin ligases in cholesterol metabolism, Diabetes Metab. J., 38, 171, 10.4093/dmj.2014.38.3.171 · DOI
  13. Volkmar, 2018, The sterol-responsive RNF145 E3 ubiquitin ligase mediates the degradation of HMG-CoA reductase together with gp78 and Hrd1, BioRxiv, 391789
  14. Miao, 2010, Tetra-glutamic acid residues adjacent to Lys248 in HMG-CoA reductase are critical for the ubiquitination mediated by gp78 and UBE2G2, Acta Biochim. Biophys. Sin., 42, 303, 10.1093/abbs/gmq022 · DOI
  15. Jo, 2011, Sterol-induced degradation of HMG CoA reductase depends on interplay of two Insigs and two ubiquitin ligases, gp78 and Trc8, Proc. Natl. Acad. Sci. Unit. States Am., 108, 20503, 10.1073/pnas.1112831108 · DOI
  16. Zelcer, 2014, The E3 ubiquitin ligase MARCH6 degrades squalene monooxygenase and affects 3-hydroxy-3-methyl-glutaryl coenzyme A reductase and the cholesterol synthesis pathway, Mol. Cell Biol., 34, 1262, 10.1128/MCB.01140-13 · DOI · Paper page
  17. Claessen, 2013, Protein quality control in the ER: balancing the ubiquitin chequebook, Trends Cell Biol., 22, 22, 10.1016/j.tcb.2011.09.010 · DOI
  18. van Wijk, 2010, The family of ubiquitin-conjugating enzymes (E2s): deciding between life and death of proteins, Faseb. J., 24, 981, 10.1096/fj.09-136259 · DOI
  19. Lenk, 2002, A role for mammalian Ubc6 homologues in ER-associated protein degradation, J. Cell Sci., 115, 3007, 10.1242/jcs.115.14.3007 · DOI
  20. van de Weijer, 2017, Multiple E2 ubiquitin- conjugating enzymes regulate human cytomegalovirus US2-mediated immunoreceptor downregulation, J. Cell Sci., 130, 2883, 10.1242/jcs.206839 · DOI
  21. Lackner, 2015, A generic strategy for CRISPR-Cas9-mediated gene tagging, Nat. Commun., 6, 4, 10.1038/ncomms10237 · DOI
  22. Lam, 2014, The human ubiquitin conjugating enzyme UBE2J2 (Ubc6) is a substrate for proteasomal degradation, Biochem. Biophys. Res. Commun., 451, 361, 10.1016/j.bbrc.2014.07.099 · DOI
  23. Zelcer, 2009, Ubiquitination of the LDL receptor, Science, 80, 100, 10.1126/science.1168974 · DOI · Paper page
  24. Sorrentino, 2012, Post-transcriptional regulation of lipoprotein receptors by the E3-ubiquitin ligase inducible degrader of the low-density lipoprotein receptor, Curr. Opin. Lipidol., 23, 213, 10.1097/MOL.0b013e3283532947 · DOI · Paper page
  25. Metzger, 2010, HECT and RING finger families of E3 ubiquitin ligases at a glance, J. Cell Sci., 125, 531, 10.1242/jcs.091777 · DOI
  26. Christianson, 2014, Cleaning up in the endoplasmic reticulum: ubiquitin in charge, Nat. Struct. Mol. Biol., 21, 325, 10.1038/nsmb.2793 · DOI
  27. Weber, 2016, Sequential poly- ubiquitylation by specialized conjugating enzymes expands the versatility of a quality control ubiquitin ligase, Mol. Cell., 63, 1, 10.1016/j.molcel.2016.07.020 · DOI

Cited by

Sorted by citations

Metadata

Authors
Tan, J. M. E., Cook, E. C. L., van den Berg, M., Scheij, S., Zelcer, N., & Loregger, A.
Venue
Atherosclerosis
Publisher
Elsevier BV
Published
2019-02
Volume
281
Pages
137-142
ISSN
0021-9150
Cited by
46
References
4
Language
en
Funders
  • Dutch Heart Foundation (2013T111, 2016T015)
  • ERC Consolidator (617376)
  • European Research Council
  • Netherlands Organization for Scientific Research (91818643)
  • AMC

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review